Citations

Citations to this article as recorded by  

• DRMref: comprehensive reference map of drug resistance mechanisms in human cancer
  Xiaona Liu, Jiahao Yi, Tina Li, Jianguo Wen, Kexin Huang, Jiajia Liu, Grant Wang, Pora Kim, Qianqian Song, Xiaobo Zhou
  Nucleic Acids Research.2024; 52(D1): D1253.     CrossRef
• Exploring the influence of microgravity on chemotherapeutic drug response in cancer: Unveiling new perspectives
  Preksha Manish Vora, Sudharshan Prabhu
  Journal of Cellular and Molecular Medicine.2024;[Epub]     CrossRef
• Abemaciclib-induced epithelial-mesenchymal transition mediated by cyclin-dependent kinase 4/6 independent of cell cycle arrest pathway
  Tomoyo Yoshimori, Masashi Kawami, Yuta Kumagai, Sorahito Futatsugi, Ryoko Yumoto, Yasuo Uchida, Mikihisa Takano
  The International Journal of Biochemistry & Cell Biology.2024; 172: 106601.     CrossRef
• SERPING1 Reduces Cell Migration via ERK‐MMP2‐MMP‐9 Cascade in Sorafenib‐ Resistant Hepatocellular Carcinoma
  Ching‐Chuan Hsieh, Yuh‐Harn Wu, Yi‐Li Chen, Chun‐I Wang, Chao‐Jen Li, I‐Hsiu Liu, Chen‐Wei Chou, Yang‐Hsiang Lin, Po‐Shuan Huang, Te‐Chia Huang, Cheng‐Yi Chen
  Environmental Toxicology.2024;[Epub]     CrossRef
• Overcoming AZD9291 Resistance and Metastasis of NSCLC via Ferroptosis and Multitarget Interference by Nanocatalytic Sensitizer Plus AHP‐DRI‐12
  Liting Wang, Hao Fu, Liwei Song, Zhihua Wu, Jian Yu, Qianqian Guo, Chuanrong Chen, Xupeng Yang, Jiali Zhang, Quan Wang, Yourong Duan, Yunhai Yang
  Small.2023;[Epub]     CrossRef
• Pomiferin targets SERCA, mTOR, and P-gp to induce autophagic cell death in apoptosis-resistant cancer cells, and reverses the MDR phenotype in cisplatin-resistant tumors in vivo
  Yuan-Qing Qu, Lin-Lin Song, Su-Wei Xu, Margaret Sum Yee Yu, Onat Kadioglu, Francesco Michelangeli, Betty Yuen Kwan Law, Thomas Efferth, Christopher Wai-Kei Lam, Vincent Kam Wai Wong
  Pharmacological Research.2023; 191: 106769.     CrossRef
• Inferring ligand-receptor cellular networks from bulk and spatial transcriptomic datasets with BulkSignalR
  Jean-Philippe Villemin, Laia Bassaganyas, Didier Pourquier, Florence Boissière, Simon Cabello-Aguilar, Evelyne Crapez, Rita Tanos, Emmanuel Cornillot, Andrei Turtoi, Jacques Colinge
  Nucleic Acids Research.2023; 51(10): 4726.     CrossRef
• RGMb impacts partial epithelial‐mesenchymal transition and BMP2‐Induced ID mRNA expression independent of PD‐L2 in nonsmall cell lung cancer cells
  Sofie Rahbek Dorset, Tina Fuglsang Daugaard, Trine Vilsbøll Larsen, Anders Lade Nielsen
  Cell Biology International.2023; 47(11): 1799.     CrossRef
• The Impacts and Changes Related to the Cancer Drug Resistance Mechanism
  Prachi Varshney, Vishal Sharma, Devdhar Yadav, Yogesh Kumar, Amit Singh, Naga Rani Kagithala, Pramod Kumar Sharma, Omji Porwal, Neeraj Kumar Fuloria, Pradeep Kumar Sharma, Ashok Kumar Gupta, Koteswara Rao GSN
  Current Drug Metabolism.2023; 24(12): 787.     CrossRef
• Quercetin Inhibits the Epithelial to Mesenchymal Transition through Suppressing Akt Mediated Nuclear Translocation of β-Catenin in Lung Cancer Cell Line
  Perumal Elumalai, Devaraj Ezhilarasan, Subramanian Raghunandhakumar
  Nutrition and Cancer.2022; 74(5): 1894.     CrossRef
• Resistance to cisplatin in human lung adenocarcinoma cells: effects on the glycophenotype and epithelial to mesenchymal transition markers
  Leonardo Marques da Fonseca, Vanessa Amil da Silva, Kelli Monteiro da Costa, Jhenifer Santos dos Reis, José Osvaldo Previato, Lucia Mendonça Previato, Leonardo Freire-de-Lima
  Glycoconjugate Journal.2022; 39(2): 247.     CrossRef
• Study on the mechanism of Cortex Lycii on lung cancer based on network pharmacology combined with experimental validation
  Zhenhui Guo, Heng Yin, Tong Wu, Shaofeng Wu, Lingyun Liu, Lei Zhang, Yanli He, Ren Zhang, Na Liu
  Journal of Ethnopharmacology.2022; 293: 115280.     CrossRef
• Statistical parametrization of cell cytoskeleton reveals lung cancer cytoskeletal phenotype with partial EMT signature
  Arkaprabha Basu, Manash K. Paul, Mitchel Alioscha-Perez, Anna Grosberg, Hichem Sahli, Steven M. Dubinett, Shimon Weiss
  Communications Biology.2022;[Epub]     CrossRef
• Fangchinoline targets epithelial–mesenchymal transition process by modulating activation of multiple cell‐signaling pathways
  Young Y. Jung, Arunachalam Chinnathambi, Tahani A. Alahmadi, Sulaiman A. Alharbi, Alan P. Kumar, Gautam Sethi, Kwang S. Ahn
  Journal of Cellular Biochemistry.2022; 123(7): 1222.     CrossRef
• Discovery of Small Molecules Simultaneously Targeting NAD(P)H:Quinone Oxidoreductase 1 and Nicotinamide Phosphoribosyltransferase: Treatment of Drug-Resistant Non-small-Cell Lung Cancer
  Kuojun Zhang, Kaizhen Wang, Xiangyu Zhang, Zhenlong Qian, Wenbo Zhang, Xiao Zheng, Jiaying Wang, Yin Jiang, Wanheng Zhang, Zhiyu Lu, Haiping Hao, Sheng Jiang
  Journal of Medicinal Chemistry.2022; 65(11): 7746.     CrossRef
• Cancer-associated fibroblasts: Origin, function, imaging, and therapeutic targeting
  Rahul Rimal, Prachi Desai, Rasika Daware, Aisa Hosseinnejad, Jai Prakash, Twan Lammers, Smriti Singh
  Advanced Drug Delivery Reviews.2022; 189: 114504.     CrossRef
• Crizotinib attenuates cancer metastasis by inhibiting TGFβ signaling in non-small cell lung cancer cells
  Soonbum Park, Eun A Cho, Jung Nyeo Chun, Da Young Lee, Sanghoon Lee, Mi Yeon Kim, Sang Mun Bae, Su In Jo, So Hee Lee, Hyun Ho Park, Tae Min Kim, Insuk So, Sang-Yeob Kim, Ju-Hong Jeon
  Experimental & Molecular Medicine.2022; 54(8): 1225.     CrossRef
• The actin cytoskeleton: Morphological changes in pre- and fully developed lung cancer
  Arkaprabha Basu, Manash K. Paul, Shimon Weiss
  Biophysics Reviews.2022;[Epub]     CrossRef
• Challenges and Opportunities in Cancer Drug Resistance
  Richard A. Ward, Stephen Fawell, Nicolas Floc’h, Vikki Flemington, Darren McKerrecher, Paul D. Smith
  Chemical Reviews.2021; 121(6): 3297.     CrossRef
• Targeted drug therapy in non-small cell lung cancer: Clinical significance and possible solutions-Part I
  Archana Upadhya, Khushwant S. Yadav, Ambikanandan Misra
  Expert Opinion on Drug Delivery.2021; 18(1): 73.     CrossRef
• Design, Synthesis and Biological Evaluation of New Pyrimidine Derivatives as Anticancer Agents
  Valentina Noemi Madia, Alice Nicolai, Antonella Messore, Alessandro De Leo, Davide Ialongo, Valeria Tudino, Francesco Saccoliti, Daniela De Vita, Luigi Scipione, Marco Artico, Samanta Taurone, Ludovica Taglieri, Roberto Di Santo, Susanna Scarpa, Roberta C
  Molecules.2021; 26(3): 771.     CrossRef
• Cytoskeletal Dynamics in Epithelial-Mesenchymal Transition: Insights into Therapeutic Targets for Cancer Metastasis
  Arpita Datta, Shuo Deng, Vennila Gopal, Kenneth Chun-Hong Yap, Clarissa Esmeralda Halim, Mun Leng Lye, Mei Shan Ong, Tuan Zea Tan, Gautam Sethi, Shing Chuan Hooi, Alan Prem Kumar, Celestial T. Yap
  Cancers.2021; 13(8): 1882.     CrossRef
• ARHGAP10 inhibits the epithelial–mesenchymal transition of non-small cell lung cancer by inactivating PI3K/Akt/GSK3β signaling pathway
  Lan-Lan Lin, Fan Yang, Dong-Huan Zhang, Cong Hu, Sheng Yang, Xiang-Qi Chen
  Cancer Cell International.2021;[Epub]     CrossRef
• Roles and Regulation of Growth differentiation factor-15 in the Immune and tumor microenvironment
  Rathna Silviya Lodi, Bin Yu, Lin Xia, Fang Liu
  Human Immunology.2021; 82(12): 937.     CrossRef
• Potential function of oxymatrine as a novel suppressor of epithelial-to-mesenchymal transition in lung tumor cells
  Young Yun Jung, Seung Ho Baek, Acharan S. Narula, Ojas A. Namjoshi, Bruce E. Blough, Kwang Seok Ahn
  Life Sciences.2021; 284: 119893.     CrossRef
• Prognostic value of epithelial‐mesenchymal transition‐inducing transcription factors in head and neck squamous cell carcinoma: A meta‐analysis
  Yuehan Wan, Haichao Liu, Ming Zhang, Zhengxian Huang, Han Zhou, Yue Zhu, Yifan Tao, Nan Xie, Xiqiang Liu, Jinsong Hou, Cheng Wang
  Head & Neck.2020; 42(5): 1067.     CrossRef
• Fucoidan increased the sensitivity to gefitinib in lung cancer cells correlates with reduction of TGFβ-mediated Slug expression
  Wei-Lun Qiu, Ai-Jung Tseng, Hsien-Yeh Hsu, Wei-Hung Hsu, Zhi-Hu Lin, Wei-Jyun Hua, Tung-Yi Lin
  International Journal of Biological Macromolecules.2020; 153: 796.     CrossRef
• Precision Management of Advanced Non–Small Cell Lung Cancer
  Ching-Yao Yang, James Chih-Hsin Yang, Pan-Chyr Yang
  Annual Review of Medicine.2020; 71(1): 117.     CrossRef
• Postpartum breast cancer progression is driven by semaphorin 7a-mediated invasion and survival
  Sarah E. Tarullo, Ryan C. Hill, Kirk C. Hansen, Fariba Behbod, Virginia F. Borges, Andrew C. Nelson, Traci R. Lyons
  Oncogene.2020; 39(13): 2772.     CrossRef
• Uptake of collagen type I via macropinocytosis cause mTOR activation and anti-cancer drug resistance
  Shota Yamazaki, Yinghan Su, Ami Maruyama, Hideki Makinoshima, Jun Suzuki, Masahiro Tsuboi, Koichi Goto, Atsushi Ochiai, Genichiro Ishii
  Biochemical and Biophysical Research Communications.2020; 526(1): 191.     CrossRef
• LncRNA H19 downregulation confers erlotinib resistance through upregulation of PKM2 and phosphorylation of AKT in EGFR-mutant lung cancers
  Chen Chen, Wei-Ran Liu, Bin Zhang, Lian-Min Zhang, Chen-Guang Li, Chang Liu, Hua Zhang, Yan-Song Huo, Yu-Chen Ma, Peng-Fei Tian, Qi Qi, Jing-Jing Li, Zhe Tang, Zhen-Fa Zhang, Giuseppe Giaccone, Dong-Sheng Yue, Chang-Li Wang
  Cancer Letters.2020; 486: 58.     CrossRef
• Low-dose naltrexone inhibits the epithelial-mesenchymal transition of cervical cancer cells in vitro and effects indirectly on tumor-associated macrophages in vivo
  Ning Liu, Mingxing Ma, Na Qu, Ruizhe Wang, Hao Chen, Fangzhu Hu, Song Gao, Fengping Shan
  International Immunopharmacology.2020; 86: 106718.     CrossRef
• Drug resistance in cancer: mechanisms and tackling strategies
  Tanweer Haider, Vikas Pandey, Nagma Banjare, Prem N. Gupta, Vandana Soni
  Pharmacological Reports.2020; 72(5): 1125.     CrossRef
• Targeting Notch signaling pathway as an effective strategy in overcoming drug resistance in ovarian cancer
  Maryam Akbarzadeh, Shabnam Akbarzadeh, Maryam Majidinia
  Pathology - Research and Practice.2020; 216(11): 153158.     CrossRef
• MicroRNA-7 targets T-Box 2 to inhibit epithelial-mesenchymal transition and invasiveness in glioblastoma multiforme
  Chih-Ming Pan, Kai-Hsiang Chan, Chao-Hsuan Chen, Chia-Ing Jan, Ming-Chao Liu, Chien-Min Lin, Der-Yang Cho, Wan-Chen Tsai, Yen-Tse Chu, Cheng-Hsin Cheng, Hao-Yu Chuang, Shao-Chih Chiu
  Cancer Letters.2020; 493: 133.     CrossRef
• Tumor Clonality and Resistance Mechanisms in EGFR Mutation-Positive Non-Small-Cell Lung Cancer: Implications for Therapeutic Sequencing
  Shinji Kohsaka, Mark Petronczki, Flavio Solca, Makoto Maemondo
  Future Oncology.2019; 15(6): 637.     CrossRef
• Epithelial-mesenchymal transition as a mechanism of resistance to tyrosine kinase inhibitors in clear cell renal cell carcinoma
  Hee Sang Hwang, Heounjeong Go, Ja-Min Park, Sun Young Yoon, Jae-Lyun Lee, Se Un Jeong, Yong Mee Cho
  Laboratory Investigation.2019; 99(5): 659.     CrossRef
• PRSS3/Mesotrypsin and kallikrein-related peptidase 5 are associated with poor prognosis and contribute to tumor cell invasion and growth in lung adenocarcinoma
  Honghai Ma, Alexandra Hockla, Christine Mehner, Matt Coban, Niv Papo, Derek C. Radisky, Evette S. Radisky
  Scientific Reports.2019;[Epub]     CrossRef
• MicroRNA-574-3p regulates epithelial mesenchymal transition and cisplatin resistance via targeting ZEB1 in human gastric carcinoma cells
  Mingqi Wang, Renwen Zhang, Shu Zhang, Rui Xu, Qing Yang
  Gene.2019; 700: 110.     CrossRef
• Association of cell cycle arrest with anticancer drug-induced epithelial-mesenchymal transition in alveolar epithelial cells
  Masashi Kawami, Risako Harada, Takamichi Ojima, Yohei Yamagami, Ryoko Yumoto, Mikihisa Takano
  Toxicology.2019; 424: 152231.     CrossRef
• Reversal of Multidrug Resistance in Cancer by Multi-Functional Flavonoids
  Qingmei Ye, Kai Liu, Qun Shen, Qingyue Li, Jinghui Hao, Fangxuan Han, Ren-Wang Jiang
  Frontiers in Oncology.2019;[Epub]     CrossRef
• BTBD7 Downregulates E-Cadherin and Promotes Epithelial-Mesenchymal Transition in Lung Cancer
  Jie Shu, Lin Wang, Fei Han, Yubin Chen, Shunjun Wang, Fanyan Luo
  BioMed Research International.2019; 2019: 1.     CrossRef
• Inhibitory effects of polyphyllins I and VII on human cisplatin-resistant NSCLC via p53 upregulation and CIP2A/AKT/mTOR signaling axis inhibition
  Fei-Fei FENG, Peng CHENG, Chao SUN, Hui WANG, Wei WANG
  Chinese Journal of Natural Medicines.2019; 17(10): 768.     CrossRef
• The Evaluation of Glioblastoma Cell Dissociation and Its Influence on Its Behavior
  Veronika Skarkova, Marketa Krupova, Barbora Vitovcova, Adam Skarka, Petra Kasparova, Petr Krupa, Vera Kralova, Emil Rudolf
  International Journal of Molecular Sciences.2019; 20(18): 4630.     CrossRef
• Bidirectional and Opposite Effects of Naïve Mesenchymal Stem Cells Ontumor Growth and Progression
  Faramarz Rahmatizadeh, Shiva Gholizadeh-Ghaleh Aziz, Khodadad Khodadadi, Maryam Lale Ataei, Esmaeil Ebrahimie, Jafar Soleimani Rad, Maryam Pashaiasl
  Advanced Pharmaceutical Bulletin.2019; 9(4): 539.     CrossRef
• Estrogen receptors promote NSCLC progression by modulating the membrane receptor signaling network: a systems biology perspective
  Xiujuan Gao, Yue Cai, Zhuo Wang, Wenjuan He, Sisi Cao, Rong Xu, Hui Chen
  Journal of Translational Medicine.2019;[Epub]     CrossRef
• CYR61/CCN1 Regulates dCK and CTGF and Causes Gemcitabine-resistant Phenotype in Pancreatic Ductal Adenocarcinoma
  Gargi Maity, Arnab Ghosh, Vijayalaxmi Gupta, Inamul Haque, Sandipto Sarkar, Amlan Das, Kakali Dhar, Sneha Bhavanasi, Sumedha S. Gunewardena, Daniel D. Von Hoff, Sanku Mallik, Suman Kambhampati, Sushanta K. Banerjee, Snigdha Banerjee
  Molecular Cancer Therapeutics.2019; 18(4): 788.     CrossRef
• Role of Cytomorphology in the Era of Liquid Biopsy
  Eduardo Clery, Pasquale Pisapia, Elena Vigliar, Umberto Malapelle, Claudio Bellevicine, Giancarlo Troncone, Fernando C. Schmitt
  Acta Cytologica.2019; 63(6): 497.     CrossRef
• TGFβ pathway inhibition in the treatment of non-small cell lung cancer
  Pınar Ö. Eser, Pasi A. Jänne
  Pharmacology & Therapeutics.2018; 184: 112.     CrossRef
• Management of acquired resistance to EGFR TKI–targeted therapy in advanced non-small cell lung cancer
  Shang-Gin Wu, Jin-Yuan Shih
  Molecular Cancer.2018;[Epub]     CrossRef
• A bibenzyl from Dendrobium ellipsophyllum induces apoptosis in human lung cancer cells
  Anirut Hlosrichok, Somruethai Sumkhemthong, Boonchoo Sritularak, Pithi Chanvorachote, Chatchai Chaotham
  Journal of Natural Medicines.2018; 72(3): 615.     CrossRef
• A miRNA-200c/cathepsin L feedback loop determines paclitaxel resistance in human lung cancer A549 cells in vitro through regulating epithelial–mesenchymal transition
  Yi-fan Zhao, Mei-ling Han, Ya-jie Xiong, Long Wang, Yao Fei, Xiao Shen, Ying Zhu, Zhong-qin Liang
  Acta Pharmacologica Sinica.2018; 39(6): 1034.     CrossRef
• Non-Coding RNAs and Resistance to Anticancer Drugs in Gastrointestinal Tumors
  Jens C. Hahne, Nicola Valeri
  Frontiers in Oncology.2018;[Epub]     CrossRef
• Bergamottin Suppresses Metastasis of Lung Cancer Cells through Abrogation of Diverse Oncogenic Signaling Cascades and Epithelial-to-Mesenchymal Transition
  Jeong-Hyeon Ko, Dongwoo Nam, Jae-Young Um, Sang Jung, Gautam Sethi, Kwang Ahn
  Molecules.2018; 23(7): 1601.     CrossRef
• Lysyl hydroxylases are transcription targets for GATA3 driving lung cancer cell metastasis
  Wei Liu, Ting Zhang, Lixia Guo, Yuanyuan Wang, Yanan Yang
  Scientific Reports.2018;[Epub]     CrossRef
• FOXC2 promotes epithelial–mesenchymal transition and cisplatin resistance of non-small cell lung cancer cells
  Yuwen He, Hui Xie, Pengjiu Yu, Shunjun Jiang, Li Wei
  Cancer Chemotherapy and Pharmacology.2018; 82(6): 1049.     CrossRef
• SPARC acts as a mediator of TGF‐β1 in promoting epithelial‐to‐mesenchymal transition in A549 and H1299 lung cancer cells
  Weichao Sun, Jianguo Feng, Qian Yi, Xichao Xu, Ying Chen, Liling Tang
  BioFactors.2018; 44(5): 453.     CrossRef
• Mechanism of Resistance to Epidermal Growth Factor Receptor-Tyrosine Kinase Inhibitors and a Potential Treatment Strategy
  Tatsuya Nagano, Motoko Tachihara, Yoshihiro Nishimura
  Cells.2018; 7(11): 212.     CrossRef
• Epigenetic suppression of E-cadherin expression by Snail2 during the metastasis of colorectal cancer
  Yue Hu, Mingrui Dai, Yayuan Zheng, Jiaxin Wu, Bin Yu, Haihong Zhang, Wei Kong, Hui Wu, Xianghui Yu
  Clinical Epigenetics.2018;[Epub]     CrossRef
• Evolution from genetics to phenotype: reinterpretation of NSCLC plasticity, heterogeneity, and drug resistance
  Yingjiao Xue, Shenda Hou, Hongbin Ji, Xiangkun Han
  Protein & Cell.2017; 8(3): 178.     CrossRef
• Benzophenone-3 increases metastasis potential in lung cancer cells via epithelial to mesenchymal transition
  Preeyaporn Plaimee Phiboonchaiyanan, Kesarin Busaranon, Chuanpit Ninsontia, Pithi Chanvorachote
  Cell Biology and Toxicology.2017; 33(3): 251.     CrossRef
• Molecular mechanisms of therapy resistance in solid tumors: chasing “moving” targets
  Laura J. Tafe
  Virchows Archiv.2017; 471(2): 155.     CrossRef
• Duchesnea indicaextract suppresses the migration of human lung adenocarcinoma cells by inhibiting epithelial-mesenchymal transition
  Pei-Ni Chen, Shun-Fa Yang, Cheng-Chia Yu, Chin-Yin Lin, Shih-Han Huang, Shu-Chen Chu, Yih-Shou Hsieh
  Environmental Toxicology.2017; 32(8): 2053.     CrossRef
• Predictive Factors for Switched EGFR-TKI Retreatment in Patients with EGFR-Mutant Non-Small Cell Lung Cancer
  Byoung Soo Kwon, Ji Hyun Park, Woo Sung Kim, Joon Seon Song, Chang-Min Choi, Jin Kyung Rho, Jae Cheol Lee
  Tuberculosis and Respiratory Diseases.2017; 80(2): 187.     CrossRef
• Polyphyllin I Overcomes EMT-Associated Resistance to Erlotinib in Lung Cancer Cells via IL-6/STAT3 Pathway Inhibition
  Wei Lou, Yan Chen, Ke-ying Zhu, Huizi Deng, Tianhao Wu, Jun Wang
  Biological & Pharmaceutical Bulletin.2017; 40(8): 1306.     CrossRef
• Primary patient-derived lung adenocarcinoma cell culture challenges the association of cancer stem cells with epithelial-to-mesenchymal transition
  Verena Tiran, Joerg Lindenmann, Luka Brcic, Ellen Heitzer, Stefanie Stanzer, Nassim Ghaffari Tabrizi-Wizsy, Elvira Stacher, Herbert Stoeger, Helmut H. Popper, Marija Balic, Nadia Dandachi
  Scientific Reports.2017;[Epub]     CrossRef
• Clusterin modulates transdifferentiation of non-small-cell lung cancer
  Runsen Jin, Xingshi Chen, Dingpei Han, Xiaoying Luo, Hecheng Li
  BMC Cancer.2017;[Epub]     CrossRef
• Growth Hormone and the Epithelial-to-Mesenchymal Transition
  Alison L Brittain, Reetobrata Basu, Yanrong Qian, John J Kopchick
  The Journal of Clinical Endocrinology & Metabolism.2017; 102(10): 3662.     CrossRef
• Silencing NUDT21 Attenuates the Mesenchymal Identity of Glioblastoma Cells via the NF-κB Pathway
  Jia-Cheng Lou, Yu-Long Lan, Jin-Xia Gao, Bin-Bin Ma, Ting Yang, Zhong-Bo Yuan, Hong-Qiang Zhang, Ting-Zhun Zhu, Ning Pan, Song Leng, Gui-Jun Song, Bo Zhang
  Frontiers in Molecular Neuroscience.2017;[Epub]     CrossRef
• Benzo(a)pyrene enhances the EMT-associated migration of lung adenocarcinoma A549 cells by upregulating Twist1
  Xi Chen, Hongbing Peng, Jian Xiao, Anqi Guan, Bin Xie, Bixiu He, Qiong Chen
  Oncology Reports.2017; 38(4): 2141.     CrossRef
• Gankyrin promotes epithelial-mesenchymal transition and metastasis in NSCLC through forming a closed circle with IL-6/ STAT3 and TGF-β/SMAD3 signaling pathway
  Wu-ping Wang, Ying Sun, Qiang Lu, Jin-bo Zhao, Xue-jiao Wang, Zhao Chen, Yun-feng Ni, Ju-zheng Wang, Yong Han, Zhi-pei Zhang, Xiao-long Yan, Xiao-fei Li
  Oncotarget.2017; 8(4): 5909.     CrossRef
• Surfactant-based drug delivery systems for treating drug-resistant lung cancer
  Prabhjot Kaur, Tarun Garg, Goutam Rath, R. S. R. Murthy, Amit K. Goyal
  Drug Delivery.2016; 23(3): 717.     CrossRef
• Moscatilin inhibits epithelial-to-mesenchymal transition and sensitizes anoikis in human lung cancer H460 cells
  Kesarin Busaranon, Preeyaporn Plaimee, Boonchoo Sritularak, Pithi Chanvorachote
  Journal of Natural Medicines.2016; 70(1): 18.     CrossRef
• SLUG is required for SOX9 stabilization and functions to promote cancer stem cells and metastasis in human lung carcinoma
  S Luanpitpong, J Li, A Manke, K Brundage, E Ellis, S L McLaughlin, P Angsutararux, N Chanthra, M Voronkova, Y C Chen, L Wang, P Chanvorachote, M Pei, S Issaragrisil, Y Rojanasakul
  Oncogene.2016; 35(22): 2824.     CrossRef
• Endothelial Transdifferentiation of Tumor Cells Triggered by the Twist1‐Jagged1‐KLF4 Axis: Relationship between Cancer Stemness and Angiogenesis
  Hsiao-Fan Chen, Kou-Juey Wu, Silvia Brunelli
  Stem Cells International.2016;[Epub]     CrossRef
• The attenuation of epithelial to mesenchymal transition and induction of anoikis by gigantol in human lung cancer H460 cells
  Thitita Unahabhokha, Pithi Chanvorachote, Varisa Pongrakhananon
  Tumor Biology.2016; 37(7): 8633.     CrossRef
• Serine/Threonine Kinase MLK4 Determines Mesenchymal Identity in Glioma Stem Cells in an NF-κB-dependent Manner
  Sung-Hak Kim, Ravesanker Ezhilarasan, Emma Phillips, Daniel Gallego-Perez, Amanda Sparks, David Taylor, Katherine Ladner, Takuya Furuta, Hemragul Sabit, Rishi Chhipa, Ju Hwan Cho, Ahmed Mohyeldin, Samuel Beck, Kazuhiko Kurozumi, Toshihiko Kuroiwa, Ryoichi
  Cancer Cell.2016; 29(2): 201.     CrossRef
• Acquired resistance to HSP90 inhibitor 17-AAG and increased metastatic potential are associated with MUC1 expression in colon carcinoma cells
  Xin Liu, Li-Li Ban, Gang Luo, Zhi-Yao Li, Yun-Feng Li, Yong-Chun Zhou, Xi-Cai Wang, Cong-Guo Jin, Jia-Gui Ye, Ding-Ding Ma, Qing Xie, You-Guang Huang
  Anti-Cancer Drugs.2016; 27(5): 417.     CrossRef
• ANGPTL4 Correlates with NSCLC Progression and Regulates Epithelial-Mesenchymal Transition via ERK Pathway
  Xiaoming Zhu, Xiaobin Guo, Sen Wu, Li Wei
  Lung.2016; 194(4): 637.     CrossRef
• Local microwave ablation with continued EGFR tyrosine kinase inhibitor as a treatment strategy in advanced non-small cell lung cancers that developed extra-central nervous system oligoprogressive disease during EGFR tyrosine kinase inhibitor treatment
  Yang Ni, Jingwang Bi, Xin Ye, Weijun Fan, Guohua Yu, Xia Yang, Guanghui Huang, Wenhong Li, Jiao Wang, Xiaoying Han, Xiang Ni, Zhigang Wei, Mingyong Han, Aimin Zheng, Min Meng, Guoliang Xue, Liang Zhang, Chao Wan
  Medicine.2016; 95(25): e3998.     CrossRef
• Effects of RECQ1 helicase silencing on non-small cell lung cancer cells
  Lin Li, Mingyang Gao, Bo Song, Hua Zhang, Yanfu Wang
  Biomedicine & Pharmacotherapy.2016; 83: 1227.     CrossRef
• Gigantol Inhibits Epithelial to Mesenchymal Process in Human Lung Cancer Cells
  Thitita Unahabhokha, Pithi Chanvorachote, Boonchoo Sritularak, Jutarat Kitsongsermthon, Varisa Pongrakhananon, Yoshiki Mukudai
  Evidence-Based Complementary and Alternative Medicine.2016;[Epub]     CrossRef
• DUOX1 silencing in lung cancer promotes EMT, cancer stem cell characteristics and invasive properties
  A C Little, D Sham, M Hristova, K Danyal, D E Heppner, R A Bauer, L M Sipsey, A Habibovic, A van der Vliet
  Oncogenesis.2016; 5(10): e261.     CrossRef
• Long range personalized cancer treatment strategies incorporating evolutionary dynamics
  Chen-Hsiang Yeang, Robert A. Beckman
  Biology Direct.2016;[Epub]     CrossRef
• Cathepsin L upregulation-induced EMT phenotype is associated with the acquisition of cisplatin or paclitaxel resistance in A549 cells
  Mei-ling Han, Yi-fan Zhao, Cai-hong Tan, Ya-jie Xiong, Wen-juan Wang, Feng Wu, Yao Fei, Long Wang, Zhong-qin Liang
  Acta Pharmacologica Sinica.2016; 37(12): 1606.     CrossRef
• Highly Expressed Integrin-α8 Induces Epithelial to Mesenchymal Transition-Like Features in Multiple Myeloma with Early Relapse
  Jiyeon Ryu, Youngil Koh, Hyejoo Park, Dae Yoon Kim, Dong Chan Kim, Ja Min Byun, Hyun Jung Lee, Sung-Soo Yoon
  Molecules and Cells.2016; 39(12): 898.     CrossRef
• Gain-of-function p53 mutant with 21-bp deletion confers susceptibility to multidrug resistance in MCF-7 cells
  SHANG-HSUN TSOU, MING-HUNG HOU, LIH-CHING HSU, TZER-MING CHEN, YEN-HUI CHEN
  International Journal of Molecular Medicine.2016; 37(1): 233.     CrossRef
• Overexpression of PAD4 suppresses drug resistance of NSCLC cell lines to gefitinib through inhibiting Elk1-mediated epithelial-mesenchymal transition
  QIONG DUAN, CUI PANG, NING CHANG, JU ZHANG, WENCHAO LIU
  Oncology Reports.2016; 36(1): 551.     CrossRef
• Iron induces cancer stem cells and aggressive phenotypes in human lung cancer cells
  Pithi Chanvorachote, Sudjit Luanpitpong
  American Journal of Physiology-Cell Physiology.2016; 310(9): C728.     CrossRef
• miR-124 modulates gefitinib resistance through SNAI2 and STAT3 in non-small cell lung cancer
  Fa-yong Hu, Xiao-nian Cao, Qin-zi Xu, Yu Deng, Sen-yan Lai, Jing Ma, Jun-bo Hu
  Journal of Huazhong University of Science and Technology [Medical Sciences].2016; 36(6): 839.     CrossRef
• Side population cells from long-term passage non-small cell lung cancer cells display loss of cancer stem cell-like properties and chemoradioresistance
  Hao Gu, Xin-Yu Wu, Rui-Tai Fan, Xin Wang, You-Zhong Guo, Rui Wang
  Oncology Letters.2016; 12(4): 2886.     CrossRef
• Ubiquilin1 represses migration and epithelial-to-mesenchymal transition of human non-small cell lung cancer cells
  P P Shah, W W Lockwood, K Saurabh, Z Kurlawala, S P Shannon, S Waigel, W Zacharias, L J Beverly
  Oncogene.2015; 34(13): 1709.     CrossRef
• AEG-1 3′-untranslated region functions as a ceRNA in inducing epithelial–mesenchymal transition of human non-small cell lung cancer by regulating miR-30a activity
  Kunmei Liu, Le Guo, Yongjian Guo, Bo Zhou, Tong Li, Hua Yang, Runting Yin, Tao Xi
  European Journal of Cell Biology.2015; 94(1): 22.     CrossRef
• SDF-1/CXCR4 signaling up-regulates survivin to regulate human sacral chondrosarcoma cell cycle and epithelial–mesenchymal transition via ERK and PI3K/AKT pathway
  Peng Yang, Gang Wang, Hongjun Huo, Qiang Li, Yan Zhao, Yuanhang Liu
  Medical Oncology.2015;[Epub]     CrossRef
• Extracellular vesicles in the biology of brain tumour stem cells – Implications for inter-cellular communication, therapy and biomarker development
  Ichiro Nakano, Delphine Garnier, Mutsuko Minata, Janusz Rak
  Seminars in Cell & Developmental Biology.2015; 40: 17.     CrossRef
• Slug contributes to cancer progression by direct regulation of ERα signaling pathway
  YOUQIANG LI, YANYUAN WU, THOMAS C. ABBATIELLO, WARREN L. WU, JU RI KIM, MARIANNA SARKISSYAN, SUREN SARKISSYAN, SEYUNG S. CHUNG, YAHYA ELSHIMALI, JAYDUTT V. VADGAMA
  International Journal of Oncology.2015; 46(4): 1461.     CrossRef
• Integrin-Linked Kinase, Snail and Multidrug Resistance Protein 1: Three concordant players in the progression of non-small cell lung cancer
  Dalia M. Abd El-Rehim, Manal I. Abd-Elghany, Maiiada H. Nazmy
  Journal of the Egyptian National Cancer Institute.2015; 27(3): 129.     CrossRef
• Next-Generation Covalent Irreversible Kinase Inhibitors in NSCLC: Focus on Afatinib
  Vera Hirsh
  BioDrugs.2015; 29(3): 167.     CrossRef
• Overview of Methods for Overcoming Hindrance to Drug Delivery to Tumors, with Special Attention to Tumor Interstitial Fluid
  Gianfranco Baronzio, Gurdev Parmar, Miriam Baronzio
  Frontiers in Oncology.2015;[Epub]     CrossRef
• Loss of FOXO1 promotes gastric tumour growth and metastasis through upregulation of human epidermal growth factor receptor 2/neu expression
  Young San Ko, Sung Jin Cho, Jinju Park, Younghoon Kim, Yong Joon Choi, Jung-Soo Pyo, Bo Gun Jang, Jong-Wan Park, Woo Ho Kim, Byung Lan Lee
  British Journal of Cancer.2015; 113(8): 1186.     CrossRef
• Epigallocatechin-3-gallate inhibits nicotine-induced migration and invasion by the suppression of angiogenesis and epithelial-mesenchymal transition in non-small cell lung cancer cells
  JINGLI SHI, FEI LIU, WENZHANG ZHANG, XIN LIU, BIHUA LIN, XUDONG TANG
  Oncology Reports.2015; 33(6): 2972.     CrossRef
• Aberrant CXCR4 and β-catenin expression in osteosarcoma correlates with patient survival
  YAO LU, GUO-FENG GUAN, JIE CHEN, BIN HU, CONG SUN, QIONG MA, YAN-HUA WEN, XIU-CHUN QIU, YONG ZHOU
  Oncology Letters.2015; 10(4): 2123.     CrossRef
• Combinatorial treatment using targeted MEK and SRC inhibitors synergistically abrogates tumor cell growth and induces mesenchymal-epithelial transition in non-small-cell lung carcinoma
  Kian Ngiap Chua, Li Ren Kong, Wen Jing Sim, Hsien Chun Ng, Weijie Richard Ong, Jean Paul Thiery, Hung Huynh, Boon Cher Goh
  Oncotarget.2015; 6(30): 29991.     CrossRef
• Radioresistant human lung adenocarcinoma cells that survived multiple fractions of ionizing radiation are sensitive to HSP90 inhibition
  Roberto Gomez-Casal, Michael W. Epperly, Hong Wang, David A. Proia, Joel S. Greenberger, Vera Levina
  Oncotarget.2015; 6(42): 44306.     CrossRef
• Clinical characteristics of non-small cell lung cancer patients who experienced acquired resistance during gefitinib treatment
  Hye-Ryoun Kim, Jae Chol Lee, Young-Chul Kim, Kyu-Sik Kim, In-Jae Oh, Sung Yong Lee, Tae Won Jang, Min Ki Lee, Kyeong-Cheol Shin, Gwan Ho Lee, Jeong-Seon Ryu, Seung Hoon Jang, Ji Woong Son, Jeong Eun Lee, Sun Young Kim, Hee Joung Kim, Kye Young Lee
  Lung Cancer.2014; 83(2): 252.     CrossRef
• GPI/AMF inhibition blocks the development of the metastatic phenotype of mature multi-cellular tumor spheroids
  Juan Carlos Gallardo-Pérez, Nadia Alejandra Rivero-Segura, Alvaro Marín-Hernández, Rafael Moreno-Sánchez, Sara Rodríguez-Enríquez
  Biochimica et Biophysica Acta (BBA) - Molecular Cell Research.2014; 1843(6): 1043.     CrossRef
• Expression of HMGA2 in bladder cancer and its association with epithelial‐to‐mesenchymal transition
  X. Ding, Y. Wang, X. Ma, H. Guo, X. Yan, Q. Chi, J. Li, Y. Hou, C. Wang
  Cell Proliferation.2014; 47(2): 146.     CrossRef
• Vimentin silencing effect on invasive and migration characteristics of doxorubicin resistant MCF-7 cells
  Okan Tezcan, Ufuk Gündüz
  Biomedicine & Pharmacotherapy.2014; 68(3): 357.     CrossRef
• Molecular characterization of scant lung tumor cells using iron-oxide nanoparticles and micro-nuclear magnetic resonance
  Arezou A. Ghazani, Melina Pectasides, Amita Sharma, Cesar M. Castro, Mari Mino-Kenudson, Hakho Lee, Jo-Anne O. Shepard, Ralph Weissleder
  Nanomedicine: Nanotechnology, Biology and Medicine.2014; 10(3): 661.     CrossRef
• Triclosan Potentiates Epithelial-To-Mesenchymal Transition in Anoikis-Resistant Human Lung Cancer Cells
  Thidarat Winitthana, Somsong Lawanprasert, Pithi Chanvorachote, Aamir Ahmad
  PLoS ONE.2014; 9(10): e110851.     CrossRef
• Rubus idaeus L Inhibits Invasion Potential of Human A549 Lung Cancer Cells by Suppression Epithelial-to-Mesenchymal Transition and Akt Pathway In Vitro and Reduces Tumor Growth In Vivo
  Shu-Chen Chu, Yih-Shou Hsieh, Li-Sung Hsu, Kuo-Shuen Chen, Chien-Cheng Chiang, Pei-Ni Chen
  Integrative Cancer Therapies.2014; 13(3): 259.     CrossRef
• The inhibitory effect of anthocyanins on Akt on invasion and epithelial-mesenchymal transition is not associated with the anti-EGFR effect of the anthocyanins
  JING NAN LU, WON SUP LEE, MIN JEONG KIM, JEONG WON YUN, JI HYUN JUNG, SANG MI YI, JAE-HOON JEONG, HYE JUNG KIM, YUNG HYUN CHOI, GON-SUP KIM, CHUNG HO RYU, SUNG CHUL SHIN
  International Journal of Oncology.2014; 44(5): 1756.     CrossRef
• Bioinformatic approaches to augment study of epithelial-to-mesenchymal transition in lung cancer
  Tim N. Beck, Adaeze J. Chikwem, Nehal R. Solanki, Erica A. Golemis
  Physiological Genomics.2014; 46(19): 699.     CrossRef
• Overexpression of c-Met increases the tumor invasion of human prostate LNCaP cancer cells in vitro and in vivo
  YILI HAN, YONG LUO, JIAHUI ZHAO, MINGCHUAN LI, YONGGUANG JIANG
  Oncology Letters.2014; 8(4): 1618.     CrossRef
• YAP-Induced Resistance of Cancer Cells to Antitubulin Drugs Is Modulated by a Hippo-Independent Pathway
  Yulei Zhao, Prem Khanal, Paul Savage, Yi-Min She, Terry D. Cyr, Xiaolong Yang
  Cancer Research.2014; 74(16): 4493.     CrossRef
• Aurora-A contributes to cisplatin resistance and lymphatic metastasis in non-small cell lung cancer and predicts poor prognosis
  Jie Xu, Cai-feng Yue, Wei-hua Zhou, Yuan-min Qian, Yan Zhang, Shao-wu Wang, An-wen Liu, Quentin Liu
  Journal of Translational Medicine.2014;[Epub]     CrossRef
• Ezrin promotes invasion and migration of the MG63 osteosarcoma cell
  Jian Zhang, Jianhong Zuo, Mingsheng Lei, Song Wu, Xiaofang Zang, Chaoyue Zhang
  Chinese Medical Journal.2014; 127(10): 1954.     CrossRef
• Personalized Cancer Medicine: Molecular Diagnostics, Predictive biomarkers, and Drug Resistance
  D Gonzalez de Castro, P A Clarke, B Al-Lazikani, P Workman
  Clinical Pharmacology & Therapeutics.2013; 93(3): 252.     CrossRef
• Epidermal Growth Factor Receptor: Pathway, Therapies, and Pipeline
  John R. Goffin, Kevin Zbuk
  Clinical Therapeutics.2013; 35(9): 1282.     CrossRef
• Silibinin suppresses EMT-driven erlotinib resistance by reversing the high miR-21/low miR-200c signature in vivo
  Sílvia Cufí, Rosa Bonavia, Alejandro Vazquez-Martin, Cristina Oliveras-Ferraros, Bruna Corominas-Faja, Elisabet Cuyàs, Begoña Martin-Castillo, Enrique Barrajón-Catalán, Joana Visa, Antonio Segura-Carretero, Jorge Joven, Joaquim Bosch-Barrera, Vicente Mico
  Scientific Reports.2013;[Epub]     CrossRef
• Silibinin meglumine, a water-soluble form of milk thistle silymarin, is an orally active anti-cancer agent that impedes the epithelial-to-mesenchymal transition (EMT) in EGFR-mutant non-small-cell lung carcinoma cells
  Sílvia Cufí, Rosa Bonavia, Alejandro Vazquez-Martin, Bruna Corominas-Faja, Cristina Oliveras-Ferraros, Elisabet Cuyàs, Begoña Martin-Castillo, Enrique Barrajón-Catalán, Joana Visa, Antonio Segura-Carretero, Joaquim Bosch-Barrera, Jorge Joven, Vicente Mico
  Food and Chemical Toxicology.2013; 60: 360.     CrossRef
• Rubus idaeus L. reverses epithelial-to-mesenchymal transition and suppresses cell invasion and protease activities by targeting ERK1/2 and FAK pathways in human lung cancer cells
  Yih-Shou Hsieh, Shu-Chen Chu, Li-Sung Hsu, Kuo-Shuen Chen, Ming-Tsung Lai, Chia-Heng Yeh, Pei-Ni Chen
  Food and Chemical Toxicology.2013; 62: 908.     CrossRef
• Alteration of the E-cadherin/β-Catenin Complex Predicts Poor Response to Epidermal Growth Factor Receptor-Tyrosine Kinase Inhibitor (EGFR-TKI) Treatment
  Seol Bong Yoo, Yu Jung Kim, Hyojin Kim, Yan Jin, Ping-Li Sun, Sanghoon Jheon, Jong Seok Lee, Jin-Haeng Chung
  Annals of Surgical Oncology.2013; 20(S3): 545.     CrossRef
• Lung cancer stem cells: a biological and clinical perspective
  Ana Koren, Helena Motaln, Tanja Cufer
  Cellular Oncology.2013; 36(4): 265.     CrossRef
• Genome-based cancer therapeutics: targets, kinase drug resistance and future strategies for precision oncology
  Paul Workman, Bissan Al-Lazikani, Paul A Clarke
  Current Opinion in Pharmacology.2013; 13(4): 486.     CrossRef
• Treatment of Non-small Cell Lung Carcinoma after Failure of Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor
  Jae Cheol Lee, Seung Hun Jang, Kye Young Lee, Young-Chul Kim
  Cancer Research and Treatment.2013; 45(2): 79.     CrossRef
• Stem cell-like ALDHbrightcellular states in EGFR-mutant non-small cell lung cancer: A novel mechanism of acquired resistance to erlotinib targetable with the natural polyphenol silibinin
  BRUNA COROMINAS-FAJA, Cristina Oliveras-Ferraros, ELISABET CUYÀS, Antonio Segura-Carretero, Jorge Joven, Begoña Martin-Castillo, ENRIQUE BARRAJÓN-CATALÁN, Vicente Micol, Joaquim Bosch-Barrera, JAVIERABEL MENENDEZ MENENDEZ
  Cell Cycle.2013; 12(21): 3390.     CrossRef
• Menadione (Vitamin K3) Induces Apoptosis of Human Oral Cancer Cells and Reduces their Metastatic Potential by Modulating the Expression of Epithelial to Mesenchymal Transition Markers and Inhibiting Migration
  Shruthy Suresh, Dinesh Raghu, Devarajan Karunagaran
  Asian Pacific Journal of Cancer Prevention.2013; 14(9): 5461.     CrossRef
• Gefitinib Inhibits Invasive Phenotype and Epithelial-Mesenchymal Transition in Drug-Resistant NSCLC Cells with MET Amplification
  Silvia La Monica, Cristina Caffarra, Francesca Saccani, Elena Galvani, Maricla Galetti, Claudia Fumarola, Mara Bonelli, Andrea Cavazzoni, Daniele Cretella, Rita Sirangelo, Rita Gatti, Marcello Tiseo, Andrea Ardizzoni, Elisa Giovannetti, Pier Giorgio Petro
  PLoS ONE.2013; 8(10): e78656.     CrossRef
• Analysis of Flora Distribution and Drug Resistance in Sputum Culture from Patients with Lung Cancer
  Feng Hao, Rui Ze Ma, Xue Yan Wang, Hui Jing Xu, Fang Fang, Li Zhang, Hui Zheng, Yu Xuan Zang, Yan Li
  Advanced Materials Research.2013; 641-642: 625.     CrossRef